Spotlight on rasburicase in anticancer therapy-induced hyperuricemia.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Volumn 20, Issue 3, 2006, Pages 197-199

  Oldfield, Vicki ^a   Perry, Caroline M ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RASBURICASE; URATE OXIDASE;

CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; HUMAN; HYPERURICEMIA; NEOPLASM; REVIEW; SALVAGE THERAPY;

ANTICARCINOGENIC AGENTS; CLINICAL TRIALS; HUMANS; HYPERURICEMIA; NEOPLASMS; SALVAGE THERAPY; URATE OXIDASE;

EID: 33750628656     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-200620030-00008     Document Type: Review

References (13)